AOD 9604 CAS NO:221231-10-3

AOD 9604 is a synthetic analog of the lipolytic domain of human GH. It is not a GHRH (growth hormone releasing hormone) like Modified GRF 1-29, and it is not a GHRP (growth hormone releasing peptide) like GHRP-2, or GHRP-6.AOD9604 actually acts on the reduction of excessive adipose tissues such as those in the abdominal area, increase in muscle mass, and enhances the lipid content of the body.It is also known as lipotropin and Tyr-hGH fragment, and is generally available these days as a transdermal cream or an injectable.

 

AOD9604 is an analog of the GRF which signals the effects of GH It is a 15-mer peptide residue of the C-terminus o to which tyrosine is added at the N-terminal end. This synthetically produced hormone is very common to weightlifters and bodybuilders because of a number of physical benefits.

Fragment (176-191) is a fat-loss peptide derived from the GH molecule, which directly initiates lipolysis and inhibits lipogenesis, but in order to better understand this peptide, it is imperative to have at least a rudimentary understanding of its parent hormone .

GH is a polypeptide which contains an amino acid sequence that is 191 amino acids in length. Frag (176-191) was developed by isolating and modifying the specific portion of the GH molecule responsible for the hormone's lipolytic and anti-lipogenic effects.

The portion of the molecule responsible for these effects is amino acids 176-191. In every sense, Frag should primarily be considered a fat loss peptide which performs these functions through the same pathways as traditional GH, but without exposing the user to the potentially undesirable side effects which may present themselves during GH administration.

Application :

The GH fragment 176-191 stimulates lipolysis and inhibits lipogenesis both en vivo/en vitro.

Fragment 176191 has shown no effect on growth or insulin resistance, unlike the full GH molecule. This is the newest, most powerful GH fragment on the market. Studies have shown sustained fatloss, aimed directly at adipose tissue.

It has been shown that the fat-reducing effects of GH appear to be controlled by a small analog region of the C-terminus end of the GH molecule. This region consists of amino acids 176-191, thus the name. This peptide fragment works by mimicking the way natural hGH regulates fat metabolism but without the adverse effects on blood sugar that is seen with unmodified hGH.

 

Studies claimed that it actually acts on the reduction of excessive adipose tissues such as those in the abdominal area, increase in muscle mass, and enhances the lipid content of the body.

AOD 9604,These segments of the synthetic peptide AOD 9604 have been researched for their in vivo effects in laboratory mice musculus. Results have shown that AOD 9604 have resulted to a short-period increase in blood glucose and a more sustained increase in plasma insulin, together with other fragments such as 172-191, 177-191 and 178-191. In addition, the researchers have suggested that functionality of the peptide depends not only in the informational sequence but should also have the correct physical configuration.

 

AOD-9604 Benefits

1. Reduces the most stubborn abdominal fat;

2. Maintains muscle mass;

3. Improve bone density fragility in Osteoporosis;

4. Accelerate soft tissue damage from injury;

5. Increases IGF-1 levels, in an effective manner, thus making this a peptide that burns fat;

6. Increases energy expenditure;

7. Imporoves lipid profiles and lipolytic activity, does not negatively impact blood glucose levels, nor does cell proliferation occur, like HGH;

8. Extremely potent and effective fat burner